Series - Policy

Policy
BIO advocates on behalf of the industry to public policy makers and influencers in United States and around the world, with these recent webinars representing a sample of BIO’s efforts to inform regulatory and legislative decision making.
Understanding the Business Implications of Global Access and Benefit Sharing Policies

September 13, 2023
Speakers: Phyllis Arthur, John Billington, Brian Dziewa, Ryan Morhard, Justin Pine, Bart Van Vooren

Join us for an important webinar for those invested in the broader biotech industry, "Understanding the Business Implications of Global Access and Benefit Sharing Policies." Tailored for members of BIO and a diverse community of stakeholders, this high-level session focuses on…

Upcoming
DNA
New SBIR Foreign Disclosure Requirements: How Does It Impact Your Company?

September 19, 2023
Speakers: Stephanie Fertig, MBA, Patricia Valdez, PhD

Following reauthorization by Congress of the SBIR/STTR Programs in 2022, there are new rules companies should familiarize themselves with concerning required disclosures of foreign affiliations or relationships with foreign countries. In addition to mandating disclosures prior…

Upcoming
Ladder of Pills
Inflation Reduction Act One Year Later—Where Are We Now?

September 27, 2023
Speakers: John Murphy, Crystal Kuntz

​It's been one year since the passage of the IRA. The Centers for Medicare & Medicaid Services has moved forward implementing the law's various provisions, including the new Medicare negotiation program and the redesign of the Medicare Part D benefit. Learn the latest…

Upcoming
photo of pills in capped bottles
Webinars
  • Show All
Results
Policy
Oct 5, 2021
Benefits of Biotechnology
Doug Berven, Steve Brody, Sasha Calder, Callie Eideberg, Colin Murphy
October 5, 2021
Policy
Sep 29, 2021
Placeholder Image
Michael Bunis, Stephanie Schonewald, Amy Bray, Wendy Plotkin
September 29, 2021